Ligase IV inhibitor SCR7 enhances gene editing directed by CRISPR–Cas9 and ssODN in human cancer cellsZheng Hu(Jilin University), Yuan‐Shan Zhu(Cornell University)Cell & BioscienceFebruary 19, 201810.1186/s13578-018-0200-zCited by 84SaveCiteExport RISWatch citationsRelated PapersTGM6 identified as a novel causative gene of spinocerebellar ataxias using exome sequencing|Brain|2010|277LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer|Frontiers in Pharmacology|2019|26Targeted disruption of the <italic>BCR-ABL</italic> fusion gene by Cas9/dual-sgRNA inhibits proliferation and induces apoptosis in chronic myeloid leukemia cells|Acta Biochimica et Biophysica Sinica|2023|1